KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Asset Writedowns and Impairment (2016 - 2023)

Merck (MRK) has disclosed Asset Writedowns and Impairment for 14 consecutive years, with $779.0 million as the latest value for Q4 2023.

  • On a quarterly basis, Asset Writedowns and Impairment fell 1.39% to $779.0 million in Q4 2023 year-over-year; TTM through Dec 2023 was $2.8 billion, a 39.36% increase, with the full-year FY2025 number at $55.0 million, up 41.03% from a year prior.
  • Asset Writedowns and Impairment was $779.0 million for Q4 2023 at Merck, down from $790.0 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $1.7 billion in Q4 2020 to a low of $15.0 million in Q3 2020.
  • A 5-year average of $501.5 million and a median of $302.0 million in 2021 define the central range for Asset Writedowns and Impairment.
  • Biggest YoY gain for Asset Writedowns and Impairment was 856.25% in 2020; the steepest drop was 97.55% in 2020.
  • Merck's Asset Writedowns and Impairment stood at $176.0 million in 2019, then soared by 856.25% to $1.7 billion in 2020, then crashed by 82.06% to $302.0 million in 2021, then surged by 161.59% to $790.0 million in 2022, then dropped by 1.39% to $779.0 million in 2023.
  • Per Business Quant, the three most recent readings for MRK's Asset Writedowns and Impairment are $779.0 million (Q4 2023), $790.0 million (Q4 2022), and $887.0 million (Q3 2022).